188 related articles for article (PubMed ID: 3464424)
21. Radioiodination of murine anti-alpha-foetoprotein E.9 monoclonal antibody and its F(ab')2 fragment for the diagnosis of hepatocellular carcinoma.
Beyers M; Aspinall S; Conradie JD; Fourie PJ
Nuklearmedizin; 1988 Jun; 27(3):87-94. PubMed ID: 2457207
[TBL] [Abstract][Full Text] [Related]
22. Radioimmunotherapy of human colon carcinoma by 131I-labelled monoclonal anti-CEA antibodies in a nude mouse model.
Buchegger F; Vacca A; Carrel S; Schreyer M; Mach JP
Int J Cancer; 1988 Jan; 41(1):127-34. PubMed ID: 3335416
[TBL] [Abstract][Full Text] [Related]
23. Localization of an anti-CEA monoclonal antibody in colo-rectal carcinoma xenografts.
Pimm MV; Armitage NC; Perkins AC; Smith W; Baldwin RW
Cancer Immunol Immunother; 1985; 19(1):8-17. PubMed ID: 3844977
[TBL] [Abstract][Full Text] [Related]
24. A rapid method for the determination of human CEA/mouse anti-CEA immune complexes in patients undergoing immunoscintigraphy.
Baum RP; Driever PH; Drahovsky D; Hör G
Eur J Nucl Med; 1989; 15(6):321-5. PubMed ID: 2767081
[TBL] [Abstract][Full Text] [Related]
25. The potential for enhanced tumour localisation by poly(ethylene glycol) modification of anti-CEA antibody.
Pedley RB; Boden JA; Boden R; Begent RH; Turner A; Haines AM; King DJ
Br J Cancer; 1994 Dec; 70(6):1126-30. PubMed ID: 7981064
[TBL] [Abstract][Full Text] [Related]
26. Biodistribution and planar gamma camera imaging of (123)I- and (131)I-labeled F(ab')(2) and Fab fragments of monoclonal antibody 14C5 in nude mice bearing an A549 lung tumor.
Burvenich IJ; Schoonooghe S; Blanckaert P; Bacher K; Vervoort L; Coene E; Mertens N; De Vos F; Slegers G
Nucl Med Biol; 2007 Apr; 34(3):257-65. PubMed ID: 17383575
[TBL] [Abstract][Full Text] [Related]
27. Immunoscintigraphy of colorectal carcinoma with F (ab')2 fragments of anti-CEA monoclonal antibody.
Buraggi G; Callegaro L; Turrin A; Gennari L; Bombardieri E; Mariani G; Deleide G; Dovis M; Gasparini M; Doci R
Cancer Detect Prev; 1987; 10(5-6):335-45. PubMed ID: 3568032
[TBL] [Abstract][Full Text] [Related]
28. Localization of human colorectal tumor xenografts in the nude mouse with the use of radiolabeled monoclonal antibody.
Zalcberg JR; Thompson CH; Lichtenstein M; Andrews J; McKenzie IF
J Natl Cancer Inst; 1983 Oct; 71(4):801-8. PubMed ID: 6578372
[TBL] [Abstract][Full Text] [Related]
29. Detection of colorectal carcinoma by emission-computerized tomography after injection of 123I-labeled Fab or F(ab')2 fragments from monoclonal anti-carcinoembryonic antigen antibodies.
Delaloye B; Bischof-Delaloye A; Buchegger F; von Fliedner V; Grob JP; Volant JC; Pettavel J; Mach JP
J Clin Invest; 1986 Jan; 77(1):301-11. PubMed ID: 3484753
[TBL] [Abstract][Full Text] [Related]
30. Construction, binding properties, metabolism, and tumor targeting of a single-chain Fv derived from the pancarcinoma monoclonal antibody CC49.
Milenic DE; Yokota T; Filpula DR; Finkelman MA; Dodd SW; Wood JF; Whitlow M; Snoy P; Schlom J
Cancer Res; 1991 Dec; 51(23 Pt 1):6363-71. PubMed ID: 1933899
[TBL] [Abstract][Full Text] [Related]
31. Preparation, characterisation and tumour targeting of cross-linked divalent and trivalent anti-tumour Fab' fragments.
Casey JL; King DJ; Chaplin LC; Haines AM; Pedley RB; Mountain A; Yarranton GT; Begent RH
Br J Cancer; 1996 Nov; 74(9):1397-405. PubMed ID: 8912535
[TBL] [Abstract][Full Text] [Related]
32. The characteristics of blood-borne radiolabels and the effect of anti-mouse IgG antibodies on localization of radiolabeled monoclonal antibody in cancer patients.
Pimm MV; Perkins AC; Armitage NC; Baldwin RW
J Nucl Med; 1985 Sep; 26(9):1011-23. PubMed ID: 3861794
[TBL] [Abstract][Full Text] [Related]
33. Localization and imaging of radiolabeled monoclonal antibodies against colorectal carcinoma in tumor-bearing nude mice.
Buchsbaum D; Lloyd R; Juni J; Wollner I; Brubaker P; Hanna D; Spicker J; Burns F; Steplewski Z; Colcher D
Cancer Res; 1988 Aug; 48(15):4324-33. PubMed ID: 3390828
[TBL] [Abstract][Full Text] [Related]
34. Biodistribution and radioimmunoscintigraphy studies of renal cell carcinoma using tumor-preferential monoclonal antibodies and F(ab')2 fragments.
Chiou RK
J Urol; 1989 Dec; 142(6):1584-8. PubMed ID: 2585642
[TBL] [Abstract][Full Text] [Related]
35. 131I-labelled tumour-specific antibodies: trial to concentrate radioisotopes specifically in tumours. 3. Improved radioimaging and tumour localization in nude mice with a monoclonal anti-CEA antibody by preincubation of labelled antibody with syngeneic spleen cells. (A rapid communication).
Makidono R; Ayabe Z; Matsuura K; Shiozaki H; Makidono A
Nihon Igaku Hoshasen Gakkai Zasshi; 1985 Feb; 45(2):388-92. PubMed ID: 4011413
[No Abstract] [Full Text] [Related]
36. Comparative binding and preclinical localization and therapy studies with radiolabeled human chimeric and murine 17-1A monoclonal antibodies.
Buchsbaum DJ; Brubaker PG; Hanna DE; Glatfelter AA; Terry VH; Guilbault DM; Steplewski Z
Cancer Res; 1990 Feb; 50(3 Suppl):993s-999s. PubMed ID: 2297753
[TBL] [Abstract][Full Text] [Related]
37. Monoclonal antibody A7 tumor localization enhancement by its F(ab')2 fragments to colon carcinoma xenografts in nude mice.
Kitamura K; Takahashi T; Yamaguchi T; Kitai S; Amagai T; Imanishi J
Jpn J Clin Oncol; 1990 Jun; 20(2):139-44. PubMed ID: 2370692
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics and tumor targeting of 131I-labeled F(ab')2 fragments of the chimeric monoclonal antibody G250: preclinical and clinical pilot studies.
Brouwers A; Mulders P; Oosterwijk E; Buijs W; Corstens F; Boerman O; Oyen W
Cancer Biother Radiopharm; 2004 Aug; 19(4):466-77. PubMed ID: 15453961
[TBL] [Abstract][Full Text] [Related]
39. Selective tumor localization of radiolabeled anti-human melanoma monoclonal antibody fragment demonstrated in the nude mouse model.
Buchegger F; Mach JP; Leonnard P; Carrel S
Cancer; 1986 Aug; 58(3):655-62. PubMed ID: 2425921
[TBL] [Abstract][Full Text] [Related]
40. Differences between the catabolism and tumour distribution of intact monoclonal antibody (791T/36) and its Fab/c fragment in mice with tumour xenografts revealed by the use of a residualizing radiolabel (dilactitol-125I-tyramine) and autoradiography.
Demignot S; Pimm MV; Thorpe SR; Baldwin RW
Cancer Immunol Immunother; 1991; 33(6):359-66. PubMed ID: 1878889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
